| Screening cognitive and academic problems in Duchenne Muscular Dystrophy: Validity and reliability of the Kempenhaeghe Learning Questionnaire | Weerkamp et al | May 2026 | Available |
| The unmet need of psychopharmacological intervention for neuropsychiatric and neurodevelopmental comorbidities in Duchenne muscular dystrophy: report of 5 workshops | Muntoni et al | March 2026 | Available |
| Screening for brain-related comorbidities in Duchenne muscular dystrophy: Construction, reliability, and validity of the BIND screener | Miranda et al | 14 January 2026 | Available |
| Hyperactivity, compulsive-like behaviours, and impaired flexibility in mouse models of Duchenne muscular dystrophy | Zarrouki et al | Accepted online 9th January 2026 | Accepted |
| Ineffective behavioral rescue despite partial brain Dp427 restoration by AAV9-U7-mediated exon 51 skipping in mdx52 mice | Vacca et al | 09 December 2025 | Available |
| Regional expression of dystrophin-gene transcripts and proteins in the mouse brain | Tetorou et al | 15 September 2025 | Available |
| Beyond muscle: Delivering RNA therapeutics to the CNS in Duchenne muscular dystrophy | Vacca et al | 29 July 2025 | Available |
| Influence of Dystrophin Isoform Deficiency on Motor Development in Duchenne Muscular Dystrophy | Chesshyre et al | 24 June 2025 | Available |
| Case Report: Home initiation of nocturnal non-invasive ventilation in two adolescents with Duchenne muscular dystrophy and comorbid autism spectrum disorder and ADHD | Weerkamp et al | 14 March 2025 | Available |
| Duchenne muscular dystrophy: recent insights in brain related comorbidities | Vaillend et al | 03 February 2025 | Available |
| The behavioural consequences of dystrophinopathy | Verhaeg et al | 01 February 2025 | Available |
| The role of dystrophin isoforms and interactors in the brain | Tetorou et al | 02 December 2024 | Available |
| Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy | Saoudi et al | 01 December 2024 | Available |
| Towards harmonization of clinical tools for assessing Brain Involvement in Dystrophinopathies (BIND); report of four expert workshops: Newcastle, Leiden, Rome, Paris | Hendriksen et al | 01 November 2024 | Available |
| Social and emotional alterations in mice lacking the short dystrophin-gene product, Dp71 | Miranda et al | 24 August 2024 | Available |
| AAV-Mediated Restoration of Dystrophin-Dp71 in the Brain of Dp71-Null Mice: Molecular, Cellular and Behavioral Outcomes | Vacca et al | 20 April 2024 | Available |
| The unconditioned fear response in vertebrates deficient in dystrophin | Gharibi et al | 12 March 2024 | Available |
| Understanding anxiety experienced by young males with Duchenne muscular dystrophy: a qualitative focus group study | Trimmer et al | 02 January 2024 | Available |
| Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model | Doisy et al | 07 December 2023 | Available |
| Psychological test usage in duchenne muscular dystrophy: An EU multi-centre study | Weerkamp et al | 22 June 2023 | Available |
| Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice | Saoudi et al | 16 March 2023 | Available |
| Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models | Saoudi et al | 15 March 2023 | Available |
| FAIRification and semantic modelling for Duchenne and Becker Muscular Dystrophy rare diseases | Perdomo-Quinteiro et al | 13 February 2023 | Available |
| A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? | Chieffo et al | 04 January 2023 | Pending |
| Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis | Weerkamp et al | 14 November 2022 | Available |
| Abnormal Expression of Synaptic and Extrasynaptic GABAA Receptor Subunits in the Dystrophin-Deficient mdx Mouse | Zarrouki et al | 20 October 2022 | Available |
| Language Development in Preschool Duchenne Muscular Dystrophy Boys | Chieffo et al | 16 September 2022 | Pending |
| Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy | Hashimoto et al | 30 May 2022 | Pending |
| Partial Restoration of Brain Dystrophin and Behavioral Deficits by Exon Skipping in the Muscular Dystrophy X-Linked (mdx) Mouse | Zarrouki et al | 19 May 2022 | Available |
| Development of a novel startle response task in Duchenne muscular dystrophy | Maresh et al | 19 April 2022 | Available |
| Improved reproducibility of diffusion kurtosis imaging using regularized non-linear optimization informed by artificial neural networks | Kerkelä et al | 15 March 2022 | Available |
| Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency | Maresh et al | 08 February 2022 | Available |
| Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy | Chesshyre et al | 26 January 2022 | Available |
| Duchenne muscular dystrophy patients lacking the dystrophin isoforms Dp140 and Dp71 and mouse models lacking Dp140 have a more severe motor phenotype | Chesshyre et al | 26 January 2022 | Available |
| Psychosocial adjustment in adults with Duchenne muscular dystrophy: A pilot study on a shortened parent-report questionnaire | Weerkamp et al | 03 November 2021 | Available |
| Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy | Saoudi et al | 21 September 2021 | Available |